KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Illumina (ILMN) over the last 17 years, with Q4 2025 value amounting to $1.4 billion.

  • Illumina's Cash & Equivalents rose 2582.08% to $1.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.4 billion, marking a year-over-year increase of 2582.08%. This contributed to the annual value of $1.4 billion for FY2025, which is 2582.08% up from last year.
  • Latest data reveals that Illumina reported Cash & Equivalents of $1.4 billion as of Q4 2025, which was up 2582.08% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Illumina's Cash & Equivalents ranged from a high of $4.4 billion in Q2 2021 and a low of $869.0 million during Q3 2024
  • Over the past 5 years, Illumina's median Cash & Equivalents value was $1.1 billion (recorded in 2024), while the average stood at $1.5 billion.
  • In the last 5 years, Illumina's Cash & Equivalents surged by 13706.21% in 2021 and then plummeted by 6952.4% in 2022.
  • Over the past 5 years, Illumina's Cash & Equivalents (Quarter) stood at $1.1 billion in 2021, then dropped by 7.41% to $1.0 billion in 2022, then increased by 4.8% to $1.0 billion in 2023, then increased by 7.54% to $1.1 billion in 2024, then rose by 25.82% to $1.4 billion in 2025.
  • Its Cash & Equivalents stands at $1.4 billion for Q4 2025, versus $1.0 billion for Q3 2025 and $934.0 million for Q2 2025.